Atlas Trials

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

Clinical trial NCT04357730 · COMPLETED

Trial details

NCT number
NCT04357730
Sponsor
Denver Health and Hospital Authority
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Acute Respiratory SyndromeRespiratory FailureAcute Respiratory Distress Syndrome
Start date
2020-05-14
Primary completion
2021-03-21
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.